WDC
60
-3
EMC
53
-3
JWN
46
-14
FOXA
56
3
OI
42
4
HAS
34
-2
ICE
67
3
MHK
48
-2
TGNA
56
-2
DLTR
44
4
GE
68
-4
KMI
63
-4
PFG
52
2
EXR
66
2
HCP
60
-2
URBN
63
13
AIG
50
2
AIV
72
-2
A
39
2
GPC
41
-3
WDC
60
-3
EMC
53
-3
JWN
46
-14
FOXA
56
3
OI
42
4
HAS
34
-2
ICE
67
3
MHK
48
-2
TGNA
56
-2
DLTR
44
4
GE
68
-4
KMI
63
-4
PFG
52
2
EXR
66
2
HCP
60
-2
URBN
63
13
AIG
50
2
AIV
72
-2
A
39
2
GPC
41
-3
Financhill
Back

Range Cancer Therapeutics ETF Vs. Virtus LifeSci Biotech Clinical Trls ETF Industry Stock Comparison

Buy
54

CNCR
Range Cancer Therapeutics ETF

Last Price:
14.00
Seasonality Move:
2.55%
Sell
45

BBC
Virtus LifeSci Biotech Clinical Trls ETF

Last Price:
27.00
Seasonality Move:
8.49%
Buy
54
Range Cancer Therapeutics ETF (CNCR) is a Buy

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $14.19. The Score for CNCR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • CNCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Virtus LifeSci Biotech Clinical Trls ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trls ETF a Buy, Sell or Hold?

  • The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $27.70. The Score for BBC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $14.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BBC Stock Price Chart

What is Virtus LifeSci Biotech Clinical Trls ETF's stock price today?

  • The Virtus LifeSci Biotech Clinical Trls ETF share price today is $27.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: 4099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.71 - 15.35) Sell
Bollinger Bands (100): (14.11 - 15.45) Sell

BBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 46.44 Sell
Chaikin Money Flow: 1036 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.97 - 30.17) Sell
Bollinger Bands (100): (26.86 - 29.48) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.6 Buy
20-day SMA: 14.43 Sell
50-day SMA: 14.76 Sell
200-day SMA: 15.02 Sell
8-day EMA: 13.87 Buy
20-day EMA: 14.22 Sell
50-day EMA: 14.57 Sell
200-day EMA: 14.54 Sell

BBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.72 Buy
20-day SMA: 28.37 Sell
50-day SMA: 28.59 Sell
200-day SMA: 27.79 Sell
8-day EMA: 27.29 Buy
20-day EMA: 27.94 Sell
50-day EMA: 28.29 Sell
200-day EMA: 27.25 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Virtus LifeSci Biotech Clinical Trls ETF Earnings Growth & BBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Virtus LifeSci Biotech Clinical Trls ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):